ProQR Therapeutics N.V. buy me8
Start price
11.02.22
/
0%
€1.40
Target price
11.02.23
-
Performance (%)
-25.71%
End price
19.02.22
€1.04
Summary
This prediction ended on 19.02.22 with a price of €1.04. The price of ProQR Therapeutics N.V. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.71%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 6.113% | 6.113% | 7.351% |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% |
According to me8 what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Bad culture
Comments by me8 for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
Buy ProQR Therapeutics N.V.
In the thread Trading ProQR Therapeutics N.V.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by me8 for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.03
22.02.22
22.02.22
€1.00
22.02.23
22.02.23
-25.24%
05.03.22
05.03.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
